Gefitinib
吉非替尼
CAS No. 184475-35-2
IRESSA
N-(3-氯-4-氟苯基)-7-甲氧基-6-(3-吗啉-4-丙氧基)喹唑啉-4-胺;易瑞沙(阿斯利康公司的抗肿瘤新药);吉非替尼(易瑞沙);吉菲替尼;吉非替尼/N-(3-氯-4-氟苯基)-7-甲氧基-6-(3-吗啉-4-丙氧基)喹唑啉-4-胺;易瑞沙(吉非替尼片);4-喹唑啉胺, N-(3-氯-4-氟苯基)-7-甲氧基-6-[3-(4-吗啉基)丙氧基]-;吉非替尼
Phosphoric acid, plutonium(4+) salt (2:1)
20190-42-5
Benzamide, N,N-dimethyl-2-nitro-
2018-71-5
3,6,9,12,15-Pentaoxaoctacosanoic acid
201986-48-3
Havellockate
201859-57-6
1-(4-(cyclopropylthio)phenyl)ethanone
918967-33-6
Benzonitrile, 3-methoxy-4-(methylthio)-
918967-42-7
Sn 2P15
201872-70-0
Bicyclo[3.3.1]nonane-9-carboxylic acid
2018-80-6
Ethanedioic acid, neptunium(4+) salt (2:1)
20196-48-9
diethyl octyl phosphate
20195-13-5
1,2-Benzenediol, 5-methyl-3-octyl-
201858-80-2
Benzonitrile, 3,5-difluoro-4-(methylthio)-
918967-38-1